Vexim has announced the expansion of its SpineJack patent portfolio in Asia. The company has received two new patents for SpineJack; one Chinese and one Japanese.
The SpineJack has undergone almost 47 patents applications gathered in three patent families. The technology is protected by international patents, in Europe, in the USA, in China, Brazil, South Korea, Australia and in South Africa.
Alongside with the protection of its intellectual property in China, Vexim is about to initiate, with a Chinese laboratory, the first biological and mechanical qualifying tests required for the registration of its products by the China Food and Drug Administration.